3M licenses dry powder inhaler platform
3M Drug Delivery has exclusively licensed Cambridge Consultants’ Conix Dry Powder Inhaler (DPI) technology platform.
The license adds to 3M’s range of inhalation technologies, giving the company an additional platform to use in the formulation of single and multi-unit dose devices.
Conix is cheaper than other inhalers and enables a large proportion of the drug to be effectively delivered to the lungs, according to Cambridge Consultants.
